Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pheochromocytoma

C V Ram1, G A Fierro-Carrion

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8899, USA.

Seminars in Nephrology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Pheochromocytoma, a rare cause of secondary hypertension, requires prompt diagnosis and management to avoid severe complications. Early recognition relies on clinical suspicion, confirmed by biochemical assays and radiological localization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Hypertension Optimal Treatment Trial: a precursor for lowering the target blood pressure level.

Current hypertension reports·2000
Same author

Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease.

Current hypertension reports·2000
Same author

Fibromuscular dysplasia of the renal arteries.

Current hypertension reports·2000
Same author

Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2000
Same author

Renovascular hypertension.

Current opinion in nephrology and hypertension·1998
Same author

Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure.

The American journal of cardiology·1997
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Area of Science:

  • Endocrinology
  • Oncology
  • Nephrology

Background:

  • Pheochromocytoma is a rare tumor causing secondary hypertension.
  • Its etiology is largely unknown, often presenting as an isolated finding.
  • Variable clinical manifestations necessitate a high index of suspicion for diagnosis.

Purpose of the Study:

  • To highlight the importance of timely recognition and management of pheochromocytoma.
  • To discuss diagnostic approaches, including biochemical and radiological methods.
  • To outline current treatment strategies for pheochromocytoma.

Main Methods:

  • Review of clinical presentations and diagnostic challenges.
  • Emphasis on biochemical assays for catecholamines and metabolites.
  • Utilization of advanced radiological techniques for tumor localization.

Related Experiment Videos

Main Results:

  • Biochemical assays significantly aid in diagnosing pheochromocytoma.
  • Radiological imaging provides straightforward tumor localization.
  • Medical treatment involves catecholamine blockade, with surgery as the primary curative option.

Conclusions:

  • Early diagnosis and management of pheochromocytoma are critical for preventing complications.
  • A combination of high clinical suspicion, biochemical testing, and radiological confirmation is essential.
  • Pharmacological blockade and surgical resection are key treatment modalities.